Analystreport

WAVE Life Sciences (WVE) had its price target lowered by Wells Fargo & Company from $27.00 to $13.00. They now have an "overweight" rating on the stock.

Wave Life Sciences Ltd. - Ordinary Shares  (WVE) 
Last wave life sciences ltd. - ordinary shares earnings: 3/2 06:45 am Check Earnings Report